Impact of alirocumab on achieving ldl-cholesterol targets in secondary prevention: real-world evidence
24 April 2026 (08:30 - 18:00)
Organised by: 
Abstract
Slides
About the speaker
UNIVERSITY HOSPITAL VIRGEN DE VALME, Seville (Spain)
84 More presentations in this session
Doctor E. Nakou (London, GB)
Professor S. Bondarev (Padua, IT)
Mrs N. Hart-Foia (Cluj Napoca, RO)
Doctor M. Audie (Bordeaux, FR)
Access the full session
The Event
ESC Preventive Cardiology 2026
24 April 2026
08:30 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Session
